ロード中...

Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients

AIM: Dolutegravir is the newest integrase inhibitor approved for HIV treatment and has demonstrated potent antiviral activity in patient populations with a broad range of treatment experience. This analysis aimed to characterize the population pharmacokinetics of dolutegravir in treatment-naive pati...

詳細記述

保存先:
書誌詳細
出版年:Br J Clin Pharmacol
主要な著者: Zhang, Jianping, Hayes, Siobhán, Sadler, Brian M, Minto, Ilisse, Brandt, Julie, Piscitelli, Steve, Min, Sherene, Song, Ivy H
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Ltd 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4574835/
https://ncbi.nlm.nih.gov/pubmed/25819132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12639
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!